DRUG BINDING INTERFACES MAPPED TO 'DB01051'
DrReposER ID | PDB | Ligand | Organism | Macromolecule | Pfam | Res. | Interface | HETATM |
---|---|---|---|---|---|---|---|---|
1AJ6_A_NOVA1 | 1aj6 | NOV DB01051(Novobiocin) | Escherichia coli | GYRASE | PF02518(HATPase_c) | 9 | ASN A 46GLU A 50ASP A 73ARG A 76ILE A 78PRO A 79ALA A 90ILE A 94THR A 165 | NOV A 1 |
1KIJ_A_NOVA400 | 1kij | NOV DB01051(Novobiocin) | Thermusthermophilus | DNA GYRASE SUBUNIT B | PF00204(DNA_gyraseB)PF02518(HATPase_c)no annotation | 16 | ILE B 10ASN A 45ASP A 48GLU A 49ASP A 72ARG A 75ILE A 77PRO A 78ASP A 80ILE A 93LYS A 102PHE A 103LYS A 109VAL A 117ARG A 135THR A 166 | NOV A 400 |
1KIJ_B_NOVB444 | 1kij | NOV DB01051(Novobiocin) | Thermusthermophilus | DNA GYRASE SUBUNIT B | PF00204(DNA_gyraseB)PF02518(HATPase_c)no annotation | 16 | ILE A 10ASN B 45ASP B 48GLU B 49ASP B 72ARG B 75ILE B 77PRO B 78ASP B 80ILE B 93TYR B 94PHE B 103VAL B 117ALA B 119ARG B 135THR B 166 | NOV B 444 |
1S14_A_NOVA1300 | 1s14 | NOV DB01051(Novobiocin) | Escherichia coli | TOPOISOMERASE IVSUBUNIT B | PF02518(HATPase_c) | 12 | ASN A1042SER A1043ASP A1045GLU A1046ASP A1069ARG A1072MET A1074PRO A1075ASP A1077ILE A1090ARG A1132THR A1163 | NOV A1300 |
1S14_B_NOVB2300 | 1s14 | NOV DB01051(Novobiocin) | Escherichia coli | TOPOISOMERASE IVSUBUNIT B | no annotation | 13 | ASN B2042SER B2043ASP B2045GLU B2046ASP B2069ARG B2072MET B2074PRO B2075ASP B2077ALA B2086ILE B2090ARG B2132THR B2163 | NOV B2300 |
3LPS_A_NOVA901 | 3lps | NOV DB01051(Novobiocin) | Xanthomonasoryzae | TOPOISOMERASE IVSUBUNIT B | PF00204(DNA_gyraseB)PF02518(HATPase_c) | 12 | ASN A 86SER A 87ASP A 89GLU A 90ASP A 113ARG A 116MET A 118PRO A 119ASP A 121ILE A 134ARG A 176THR A 207 | NOV A 901 |
4URN_A_NOVA2000 | 4urn | NOV DB01051(Novobiocin) | Staphylococcusaureus | DNA TOPOISOMERASEIV, B SUBUNIT | PF02518(HATPase_c)no annotation | 14 | ASP B 35LYS B 36ASN A 49SER A 50ASP A 52GLU A 53ASP A 76ARG A 79MET A 81PRO A 82ILE A 96ARG A 138THR A 168ASN B 186 | NOV A2000 |
4URN_B_NOVB2000 | 4urn | NOV DB01051(Novobiocin) | Staphylococcusaureus | DNA TOPOISOMERASEIV, B SUBUNIT | no annotation | 11 | ASN B 49SER B 50ASP B 52GLU B 53ASP B 76ARG B 79MET B 81PRO B 82ILE B 96ARG B 138THR B 168 | NOV B2000 |
4URN_C_NOVC2000 | 4urn | NOV DB01051(Novobiocin) | Staphylococcusaureus | DNA TOPOISOMERASEIV, B SUBUNIT | no annotation | 11 | ASN C 49SER C 50ASP C 52GLU C 53ASP C 76ARG C 79MET C 81PRO C 82ILE C 96ARG C 138THR C 168 | NOV C2000 |
4URO_A_NOVA2000 | 4uro | NOV DB01051(Novobiocin) | Staphylococcusaureus | DNA GYRASE SUBUNIT B | PF02518(HATPase_c)no annotation | 15 | ASN A 54SER A 55ASP A 57GLU A 58ASP A 81ARG A 84ILE A 86PRO A 87ASP A 89GLN A 91ILE A 102SER A 128ARG A 144THR A 173ARG D 200 | NOV A2000 |
4URO_B_NOVB2000 | 4uro | NOV DB01051(Novobiocin) | Staphylococcusaureus | DNA GYRASE SUBUNIT B | no annotation | 13 | ASN B 54SER B 55ASP B 57GLU B 58ASP B 81ARG B 84ILE B 86PRO B 87ASP B 89GLN B 91ILE B 102SER B 128ARG B 144 | NOV B2000 |
4URO_C_NOVC2000 | 4uro | NOV DB01051(Novobiocin) | Staphylococcusaureus | DNA GYRASE SUBUNIT B | no annotation | 14 | ASN C 54ASP C 57GLU C 58ASP C 81ARG C 84ILE C 86PRO C 87ASP C 89GLN C 91ALA C 98ILE C 102SER C 128ARG C 144THR C 173 | NOV C2000 |
4URO_D_NOVD2000 | 4uro | NOV DB01051(Novobiocin) | Staphylococcusaureus | DNA GYRASE SUBUNIT B | no annotation | 12 | ASN D 54SER D 55GLU D 58ASP D 81ARG D 84ILE D 86PRO D 87ASP D 89ILE D 102SER D 128ARG D 144THR D 173 | NOV D2000 |
6B89_A_NOVA403 | 6b89 | NOV DB01051(Novobiocin) | Escherichia coli | LIPOPOLYSACCHARIDEEXPORT SYSTEMATP-BINDING PROTEINLPTB | no annotation | 16 | LEU A 72HIS A 73ALA A 76TYR A 82PRO A 84GLU A 86SER A 88PHE A 90PHE B 90ARG B 91ARG B 92LEU B 93ALA B 101VAL A 102GLN B 136ARG A 150 | NOV A 403 |
6B89_B_NOVB403 | 6b89 | NOV DB01051(Novobiocin) | Escherichia coli | LIPOPOLYSACCHARIDEEXPORT SYSTEMATP-BINDING PROTEINLPTB | no annotation | 17 | LEU B 72HIS B 73ALA B 76TYR B 82PRO B 84GLU B 86SER B 88PHE A 90PHE B 90ARG A 91ARG A 92LEU A 93ALA A 101VAL B 102GLN A 104GLN A 136ARG B 150 | NOV B 403 |